Category Archives: BioUtah News

U.S. Study of DiscGenics IDCT Achieves One-Year Follow-Up Milestone

By Denise Bell | Published April 30, 2021

DiscGenics, a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, has completed enrollment in its Japanese safety study of Injectable Discogenic Cell Therapy (IDCT) for lumbar disc degeneration, a major cause of chronic low back pain. This Japanese 38-subject […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India

By Denise Bell | Published April 30, 2021

Co-Diagnostics’ Indian manufacturing facility, CoSara Diagnostics Pvt. Ltd. (“CoSara,” or the “JV”, a Joint Venture with Synbiotics Ltd) has been featured in recent press highlighting its actions to provide COVID-19 diagnostics as a surge of infections has led to the world’s worst COVID-19 outbreak since the pandemic began. The article in the Times of India […]

Also posted in COVID-19 Updates, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Canary Speech and Constant Companion Partner to Help Diagnose Behavioral Health Issues

By Denise Bell | Published April 30, 2021

Utah Business Magazine has highlighted a new partnership between Constant Companion and Canary Speech to study how voice technology can be used to identify human conditions in specific populations. Canary Speech will analyze the data with its patented speech digital biomarker technology, used to diagnose behavioral conditions and other diseases. Constant Companion will be utilizing its […]

Also posted in Utah's Life Sciences Companies | | Leave a comment

UNIVERSITY OF UTAH, ARUP, AND TECHCYTE DEVELOP NANOSPOT.AI, A NEW ULTRA-FAST TEST FOR COVID-19 ANTIBODIES

By Denise Bell | Published April 30, 2021

The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer COVID-19 antibody test. NanoSpot.AI is estimated to be significantly less expensive to manufacture than other antibody tests, so it has the potential to be much more affordable and extend […]

Also posted in COVID-19 Updates, Utah's Life Sciences Companies | | Leave a comment

BioUtah Statement on House Democrat Leaders Drug Pricing Legislation

By Lori Ross | Published April 23, 2021

Salt Lake City, Utah (April 22, 2021) – BioUtah President and CEO, Kelvyn Cullimore, issued the following statement after House Democrat leaders released their drug pricing proposal, H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, based upon similar legislation introduced in the 116th Congress. “Utah has a long and proud history of […]

Also posted in Policy News, Press Releases | | Leave a comment

Introducing the ReddyPortTM Microphone and Controller Technology Allowing Communication for Patients on Non- Invasive Ventilation

By Denise Bell | Published April 23, 2021

ReddyPort has launched the ReddyPortTM Microphone and Controller, a first-of-its-kind device that includes a single-patient use microphone which integrates withReddyPortTM Elbow, providing an interface for application of continuous positive airway pressure (CPAP) or bi-level therapy. ReddyPort Microphone and Controller is a proprietary system enabling clinicians and patients to communicate clearly with one another and their […]

| Leave a comment

Sumitomo Dainippon Pharma Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021

By Lori Ross | Published April 20, 2021

CAMBRIDGE, Mass., April 10, 2021 — Sumitomo Dainippon Pharma Oncology, Inc., a clinicalstage company focused on research and development for novel cancer therapeutics, today presented new findings on a range of investigational agents from the company’s pipeline at the American Association for Cancer Research (AACR) Virtual Annual Meeting I, taking place April 10-15, 2021. The […]

| Leave a comment